Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.
Giammona A, De Vellis C, Crivaro E, Maresca L, Amoriello R, Ricci F, Anichini G, Pietrobono S, Pease DR, Fernandez-Zapico ME, Ballerini C, Stecca B. Giammona A, et al. Among authors: pietrobono s. J Exp Clin Cancer Res. 2024 Aug 2;43(1):214. doi: 10.1186/s13046-024-03138-0. J Exp Clin Cancer Res. 2024. PMID: 39090759 Free PMC article.
Injectable Thermogelling Nanostructured Ink as Simultaneous Optical and Magnetic Resonance Imaging Contrast Agent for Image-Guided Surgery.
Cressoni C, Malandra S, Milan E, Boschi F, Nicolato E, Negri A, Veccia A, Bontempi P, Mangiameli D, Pietrobono S, Melisi D, Marzola P, Antonelli A, Speghini A. Cressoni C, et al. Among authors: pietrobono s. Biomacromolecules. 2024 Jun 10;25(6):3741-3755. doi: 10.1021/acs.biomac.4c00312. Epub 2024 May 23. Biomacromolecules. 2024. PMID: 38783486
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial.
Melisi D, Zecchetto C, Merz V, Malleo G, Landoni L, Quinzii A, Casalino S, Fazzini F, Gaule M, Pesoni C, Casetti L, Esposito A, Marchegiani G, Piazzola C, D'Onofrio M, de Robertis R, Gabbrielli A, Bernardoni L, Crino SF, Pietrobono S, Luchini C, Aliberti C, Martignoni G, Milleri S, Butturini G, Scarpa A, Salvia R, Bassi C. Melisi D, et al. Among authors: pietrobono s. Eur J Cancer. 2024 Jan;196:113430. doi: 10.1016/j.ejca.2023.113430. Epub 2023 Nov 11. Eur J Cancer. 2024. PMID: 37995598 Free article. Clinical Trial.
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer.
Bencivenga M, Torroni L, Dal Cero M, Quinzii A, Zecchetto C, Merz V, Casalino S, Taus F, Pietrobono S, Mangiameli D, Filippini F, Alloggio M, Castelli C, Iglesias M, Pera M, Melisi D. Bencivenga M, et al. Among authors: pietrobono s. J Pers Med. 2023 Aug 24;13(9):1294. doi: 10.3390/jpm13091294. J Pers Med. 2023. PMID: 37763062 Free PMC article.
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma.
Pietrobono S, Sabbadini F, Bertolini M, Mangiameli D, De Vita V, Fazzini F, Lunardi G, Casalino S, Scarlato E, Merz V, Zecchetto C, Quinzii A, Di Conza G, Lahn M, Melisi D. Pietrobono S, et al. Cancer Res. 2024 Jan 2;84(1):118-132. doi: 10.1158/0008-5472.CAN-23-0104. Cancer Res. 2024. PMID: 37738399 Free PMC article. Clinical Trial.
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab.
Zecchetto C, Quinzii A, Casalino S, Gaule M, Pesoni C, Merz V, Pietrobono S, Mangiameli D, Pasquato M, Milleri S, Giacopuzzi S, Bencivenga M, Tomezzoli A, de Manzoni G, Melisi D. Zecchetto C, et al. Among authors: pietrobono s. J Pers Med. 2023 Mar 11;13(3):508. doi: 10.3390/jpm13030508. J Pers Med. 2023. PMID: 36983691 Free PMC article.
29 results